Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71610-838

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71610-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)

Chemical structure diagram showing the molecular arrangement of Lisinopril dihydrate, one of the active ingredients in Lisinopril and Hydrochlorothiazide tablets. The structure includes chemical bonds and functional groups with two water molecules represented.*

FDA Label Image

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)

Chemical structure diagram of the active ingredient hydrochlorothiazide, showing its molecular configuration with labeled functional groups and atoms.*

FDA Label Image

Label (71610 0838 30)

Label for Lisinopril and Hydrochlorothiazide USP tablets, 20 mg/12.5 mg strength, in a package containing 30 tablets. The label includes storage instructions, manufacturer Lupin Limited in Nagpur, India, and repackager Aphena Pharma in Cookeville, Tennessee. The NDC number is 71610-838-30.*

FDA Label Image

Aphena (Aphena)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.